Enovis Price to Book Ratio 2012-2025 | ENOV
Historical price to book ratio values for Enovis (ENOV) over the last 10 years. The current price to book ratio for Enovis as of January 14, 2026 is 0.70.
| Enovis Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-14 | 24.27 | 0.69 | |
| 2025-09-30 | 30.34 | $35.39 | 0.86 |
| 2025-06-30 | 31.36 | $45.15 | 0.69 |
| 2025-03-31 | 38.21 | $45.87 | 0.83 |
| 2024-12-31 | 43.88 | $45.89 | 0.96 |
| 2024-09-30 | 43.05 | $59.67 | 0.72 |
| 2024-06-30 | 45.20 | $59.94 | 0.75 |
| 2024-03-31 | 62.45 | $60.37 | 1.03 |
| 2023-12-31 | 56.02 | $62.65 | 0.89 |
| 2023-09-30 | 52.73 | $63.08 | 0.84 |
| 2023-06-30 | 64.12 | $63.28 | 1.01 |
| 2023-03-31 | 53.49 | $63.22 | 0.85 |
| 2022-12-31 | 53.52 | $63.62 | 0.84 |
| 2022-09-30 | 46.07 | $62.94 | 0.73 |
| 2022-06-30 | 55.00 | $64.52 | 0.85 |
| 2022-03-31 | 68.49 | $85.95 | 0.80 |
| 2021-12-31 | 79.12 | $89.50 | 0.88 |
| 2021-09-30 | 79.00 | $89.76 | 0.88 |
| 2021-06-30 | 78.85 | $91.73 | 0.86 |
| 2021-03-31 | 75.40 | $94.95 | 0.79 |
| 2020-12-31 | 65.82 | $90.84 | 0.72 |
| 2020-09-30 | 53.98 | $87.57 | 0.62 |
| 2020-06-30 | 48.02 | $86.05 | 0.56 |
| 2020-03-31 | 34.08 | $84.63 | 0.40 |
| 2019-12-31 | 62.62 | $88.68 | 0.71 |
| 2019-09-30 | 50.02 | $79.82 | 0.63 |
| 2019-06-30 | 48.24 | $83.03 | 0.58 |
| 2019-03-31 | 51.08 | $95.50 | 0.53 |
| 2018-12-31 | 35.97 | $88.95 | 0.40 |
| 2018-09-30 | 62.07 | $89.05 | 0.70 |
| 2018-06-30 | 52.75 | $89.24 | 0.59 |
| 2018-03-31 | 54.91 | $93.34 | 0.59 |
| 2017-12-31 | 68.19 | $90.74 | 0.75 |
| 2017-09-30 | 71.67 | $85.63 | 0.84 |
| 2017-06-30 | 67.76 | $82.24 | 0.82 |
| 2017-03-31 | 67.57 | $78.34 | 0.86 |
| 2016-12-31 | 61.84 | $75.59 | 0.82 |
| 2016-09-30 | 54.10 | $77.51 | 0.70 |
| 2016-06-30 | 45.54 | $77.25 | 0.59 |
| 2016-03-31 | 49.21 | $79.25 | 0.62 |
| 2015-12-31 | 40.19 | $79.12 | 0.51 |
| 2015-09-30 | 51.48 | $79.79 | 0.65 |
| 2015-06-30 | 79.43 | $82.81 | 0.96 |
| 2015-03-31 | 82.15 | $78.71 | 1.04 |
| 2014-12-31 | 88.76 | $81.29 | 1.09 |
| 2014-09-30 | 98.06 | $85.80 | 1.14 |
| 2014-06-30 | 128.30 | $88.54 | 1.45 |
| 2014-03-31 | 122.77 | $82.48 | 1.49 |
| 2013-12-31 | 109.62 | $80.69 | 1.36 |
| 2013-09-30 | 97.23 | $75.67 | 1.28 |
| 2013-06-30 | 89.69 | $70.86 | 1.27 |
| 2013-03-31 | 80.10 | $65.81 | 1.22 |
| 2012-12-31 | 69.45 | $68.78 | 1.01 |
| 2012-09-30 | 63.12 | $69.59 | 0.91 |
| 2012-06-30 | 47.45 | $67.24 | 0.71 |
| 2012-03-31 | 60.65 | $71.01 | 0.85 |
| 2011-12-31 | 49.02 | $13.00 | 3.77 |
| 2011-09-30 | 34.87 | $16.89 | 2.06 |
| 2011-06-30 | 42.69 | $17.51 | 2.44 |
| 2011-03-31 | 39.50 | $16.40 | 2.41 |
| 2010-12-31 | 31.69 | $14.95 | 2.12 |
| 2010-09-30 | 25.59 | $15.63 | 1.64 |
| 2010-06-30 | 17.92 | $12.76 | 1.40 |
| 2010-03-31 | 20.26 | $13.41 | 1.51 |
| 2009-12-31 | 20.72 | $15.05 | 1.38 |
| 2009-09-30 | 18.30 | $13.65 | 1.34 |
| 2009-06-30 | 13.29 | $12.73 | 1.04 |
| 2009-03-31 | 11.82 | $11.71 | 1.01 |
| 2008-12-31 | 17.88 | $11.59 | 1.54 |
| 2008-09-30 | 28.76 | $16.20 | 1.78 |
| 2008-06-30 | 43.18 | $15.85 | 2.72 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.410B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.560B | 43.44 |
| Tempus AI (TEM) | United States | $11.946B | 0.00 |
| Doximity (DOCS) | United States | $7.787B | 32.06 |
| Hims & Hers Health (HIMS) | United States | $7.330B | 59.63 |
| IRhythm Technologies (IRTC) | United States | $5.008B | 0.00 |
| Hinge Health (HNGE) | United States | $3.710B | 0.00 |
| Privia Health (PRVA) | United States | $2.835B | 177.31 |
| Heartflow (HTFL) | United States | $2.731B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.687B | 44.45 |
| 10x Genomics (TXG) | United States | $2.597B | 0.00 |
| Omnicell (OMCL) | United States | $2.306B | 47.15 |
| Azenta (AZTA) | United States | $1.771B | 72.64 |
| Schrodinger (SDGR) | United States | $1.349B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.312B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.111B | 0.00 |
| Phreesia (PHR) | United States | $1.000B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.877B | 0.00 |
| Talkspace (TALK) | United States | $0.659B | 132.67 |
| Standard BioTools (LAB) | United States | $0.627B | 0.00 |
| Claritev (CTEV) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.448B | 0.00 |
| Carlsmed (CARL) | United States | $0.379B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.355B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 15.14 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.268B | 0.00 |
| CapsoVision (CV) | United States | $0.266B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.207B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.178B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.124B | 6.81 |
| Outset Medical (OM) | United States | $0.093B | 0.00 |
| HeartBeam (BEAT) | United States | $0.083B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.079B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Precipio (PRPO) | United States | $0.045B | 0.00 |
| 111 (YI) | China | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.023B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |